Clinical impact of early enteral versus parenteral nutrition following cystectomy and extended pelvic lymphadenectomy

ISRCTN ISRCTN79535150
DOI https://doi.org/10.1186/ISRCTN79535150
Protocol serial number 160/10
Sponsor Inselspital, University Hospital Berne (Switzerland)
Funder Inselspital, University Hospital Berne (Switzerland) - Urology Department (Urologische Universitätsklinik)
Submission date
25/06/2010
Registration date
07/07/2010
Last edited
18/07/2013
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Beat Roth
Scientific

Inselspital
Urology Department (Urologische Universitätsklinik)
Bern
3010
Switzerland

Study information

Primary study designInterventional
Study designProspective single centre double blind randomised trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleClinical impact of early enteral versus parenteral nutrition following cystectomy evaluated in a prospective randomised trial
Study objectivesCurrent opinion favours the use of postoperative early enteral over parenteral nutrition, although the benefits in cystectomy patients have never been clearly shown. The aim of this study is to evaluate the clinical impact of early enteral versus total parenteral nutrition following cystectomy.
Ethics approval(s)The Ethics Committee of the Canton of Bern (Ethikkommission des Kantons Bern) approved originally in November 2007. The trial was not started and approval was re-sought and granted in May 2010 (ref: 1394)
Health condition(s) or problem(s) studiedBladder cancer / invasive disease / Urology
InterventionAfter cystectomy and extended pelvic lymphadenectomy patients are randomized into one of the following groups:
1. Group A: parenteral nutrition is given for 7 days; oral intake with a gastrostomy tube in place is started on day 4 after surgery
2. Group B: oral food is given the first day after surgery. No parenteral nutrition. Saline solution for volume substitution
Intervention typeOther
Primary outcome measure(s)

Occurrence of postoperative complications according to the Dindo-Clavien classification with particular respect for infections. Measured within the first 30 days after surgery

Key secondary outcome measure(s)

1. Recovery of bowel function (flatulence, passage of stool, nausea, vomiting)
2. Length of postoperative hospital stay
3. Nutritional biochemical variables
3.1. Serum albumin
3.2. Prealbumin
3.3. Total protein
Measured by questionnaire and blood samples on postoperative day 1, 3, 7, 10, 14 and 30 days after surgery.

Completion date01/03/2012
Reason abandoned (if study stopped)Objectives no longer viable

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration198
Key inclusion criteria1. Consecutive series of 198 patients with invasive bladder cancer scheduled for cystectomy and extended pelvic lymph node dissection
2. Age >18 years
Key exclusion criteria1. Age <18y
2. Pregnancy
3. No informed consent available
4. Previous radiotherapy to the pelvis
5. Prior bowel surgery
Date of first enrolment01/07/2010
Date of final enrolment01/03/2012

Locations

Countries of recruitment

  • Switzerland

Study participating centre

Inselspital
Bern
3010
Switzerland

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/03/2013 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes